Philina Lee Net Worth & Insider Trades

Philina Lee - CHIEF COMMERCIAL OFFICER, Blueprint Medicines Corp

As of March 8, 2023

What is Philina Lee's Net Worth?

The current estimated net worth of Blueprint Medicines Corp's CHIEF COMMERCIAL OFFICER, Philina Lee, is estimated to be about $2.32M . Philina Lee owns about 31,178 units of Blueprint Medicines Corp common stock. Recently at Blueprint Medicines Corp, Philina Lee has sold an estimated value of $76.56K worth.

What is Philina Lee's Past Insider Trading?

Philina Lee's largest sale order was 1,676 units , worth over $76.56K on March 8, 2023. In total, Philina Lee has made about 2 transactions recently at Blueprint Medicines Corp. Philina Lee usually trades in March, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Philina Lee's' Mailing Address?

  • Mailing address is C/o Fusion Pharmaceuticals, Inc. 270 Longwood Road South Hamilton D0 L8P OA6 Bermuda

Blueprint Medicines Corp Executive Compensation

Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found


What are Blueprint Medicines Corp's Past Insider Trades?

Blueprint Medicines Corp's most recent insider trade came on December 6, 2023 by Christopher Murray who sold 600 units worth $42.86K . In the last 8 years, insiders at Blueprint Medicines Corp have sold an estimated value of $180.39M and bought an estimated value of $18.29M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers,  Kate Haviland, CHIEF EXECUTIVE OFFICER,  and Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER .

Blueprint Medicines Corp Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found